Accéder au contenu
Merck

524628

Phosphatase Inhibitor Cocktail IV

liquid, for the inhibition of serine/threonine and alkaline phosphatases

Synonyme(s) :

Phosphatase Inhibitor

Se connecter pour consulter les tarifs organisationnels et contractuels.

Sélectionner une taille de conditionnement

A propos de cet article

UNSPSC Code:
12352200
NACRES:
NA.54
Form:
liquid
Solubility:
water: soluble
Storage temp.:
−20°C

Principaux documents

Voir toute la documentation
Service technique
Besoin d'aide ? Notre équipe de scientifiques expérimentés est là pour vous.
Laissez-nous vous aider
Service technique
Besoin d'aide ? Notre équipe de scientifiques expérimentés est là pour vous.
Laissez-nous vous aider

Nom du produit

Phosphatase Inhibitor Cocktail Set IV, Phosphatase inhibitor Cocktail Set IV is a cocktail of three phosphatase inhibitors for the inhibition of both serine/threonine and alkaline phosphatases.

form

liquid

manufacturer/tradename

Calbiochem®

storage condition

OK to freeze
protect from light

solubility

water: soluble

shipped in

wet ice

storage temp.

−20°C

Catégories apparentées

Biochem/physiol Actions

Cell permeable: no
Primary Target
Serine/threonine and alkaline phosphatases
Product does not compete with ATP.
Reversible: no

Disclaimer

Toxicity: Highly Toxic (H)

General description

A cocktail of three phosphatase inhibitors specially formulated for inhibition of alkaline phosphatases as well as serine/threonine protein phosphatases such as PP1 and PP2A. May be used with cell lysates and tissue extracts, including extracts containing detergents. Supplied as 1 ml or a set of five 1 ml vials. Each vial contains 1 ml phosphatase inhibitor cocktail solubilized in 95% DMSO, consisting of the following components:

Physical form

In 95% DMSO.

Preparation Note

For long-term storage, aliquot and freeze (-20°C). Dilute 1:50 just prior to use.

Legal Information

CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany

Classe de stockage

10 - Combustible liquids

wgk

WGK 1

flash_point_f

188.6 °F - (refers to pure substance)

flash_point_c

87 °C - (refers to pure substance)

Certificats d'analyse (COA)

Recherchez un Certificats d'analyse (COA) en saisissant le numéro de lot du produit. Les numéros de lot figurent sur l'étiquette du produit après les mots "Lot" ou "Batch".

Déjà en possession de ce produit ?

Retrouvez la documentation relative aux produits que vous avez récemment achetés dans la Bibliothèque de documents.

Consulter la Bibliothèque de documents

Jooyoung Lim et al.
International journal of stem cells, 17(3), 284-297 (2024-04-12)
Acetaldehyde dehydrogenase 2 (ALDH2) is the second enzyme involved in the breakdown of acetaldehyde into acetic acid during the process of alcohol metabolism. Roughly 40% of East Asians carry one or two ALDH2*2 alleles, and the presence of ALDH2 genetic
Stephane Angers
Methods in molecular biology (Clifton, N.J.), 468, 223-230 (2008-12-23)
Multiple screens performed in Drosophila, Caenorhabditis elegans, Xenopus, and zebrafish have identified dozens of proteins participating in Wnt signal transduction. Epistasis experiments, enhancer and suppressor screens, and protein-protein interaction techniques have also been efficient at finding new pathway members, connecting
Heeju Han et al.
Scientific reports, 12(1), 6416-6416 (2022-04-21)
Post-inflammatory hyperpigmentation is a skin discoloration process that occurs following an inflammatory response or wound. As the skin begins to heal, macrophages first exhibit a proinflammatory phenotype (M1) during the early stages of tissue repair and then transition to a
Chunwan Lu et al.
Oncogene, 41(18), 2651-2662 (2022-03-31)
The role of glucose-6-phosphate dehydrogenase (G6PD) in human cancer is incompletely understood. In a metabolite screening, we observed that inhibition of H3K9 methylation suppressed aerobic glycolysis and enhances the PPP in human mesothelioma cells. Genome-wide screening identified G6PD as an
T Pulinilkunnil et al.
International journal of obesity (2005), 38(2), 205-215 (2013-07-03)
Although obesity increases the risk of developing cardiomyopathy, the mechanisms underlying the development of this cardiomyopathy are incompletely understood. As obesity is also associated with increased intramyocardial triacylglycerol (TAG) deposition, also referred to as cardiac steatosis, we hypothesized that alterations
Afficher tous les articles scientifiques apparentés

Notre équipe de scientifiques dispose d'une expérience dans tous les secteurs de la recherche, notamment en sciences de la vie, science des matériaux, synthèse chimique, chromatographie, analyse et dans de nombreux autres domaines..

Contacter notre Service technique